44 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
30
Fragment-Based Discovery of 2-Aminoquinazolin-4(3H)-ones As Novel Class Nonpeptidomimetic Inhibitors of the Plasmepsins I, II, and IV.
Latvian Institute of Organic Synthesis
2
Chalcone scaffolds as anti-infective agents: structural and molecular target perspectives.
Guru Ghasidas Vishwavidyalaya (A Central University)
20
Plasmepsin inhibitory activity and structure-guided optimization of a potent hydroxyethylamine-based antimalarial hit.
Latvian Institute of Organic Synthesis
12
Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum.
Kyoto Pharmaceutical University
1
Evaluation of aminohydantoins as a novel class of antimalarial agents.
Saint Louis University
5
Discovery of non-peptide inhibitors of Plasmepsin II by structure-based virtual screening.
East China University of Science and Technology
3
Identification of acridinyl hydrazides as potent aspartic protease inhibitors.
University of Karachi
34
Incorporating molecular shape into the alignment-free Grid-Independent Descriptors.
Universitat Pompeu Fabra
9
Plasmepsin II inhibition and antiplasmodial activity of Primaquine-Statine 'double-drugs'.
University of Milan
17
Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library.
Pharmacopeia
11
New benzimidazole derivatives as antiplasmodial agents and plasmepsin inhibitors: synthesis and analysis of structure-activity relationships.
University of Karachi
8
Identification of plasmepsin inhibitors as selective anti-malarial agents using ligand based drug design.
Trinity College
1
Quinolines and structurally related heterocycles as antimalarials.
National Institute of Pharmaceutical Education and Research
13
Improvement of both plasmepsin inhibitory activity and antimalarial activity by 2-aminoethylamino substitution.
Kyoto Pharmaceutical University
8
Mechanism-based inhibitors of the aspartyl protease plasmepsin II as potential antimalarial agents.
Wayne State University
12
alpha-Substituted norstatines as the transition-state mimic in inhibitors of multiple digestive vacuole malaria aspartic proteases.
Uppsala University
5
Recent developments in the design and synthesis of hybrid molecules based on aminoquinoline ring and their antiplasmodial evaluation.
Universidad Industrial De Santander
7
Expedient solid-phase synthesis of both symmetric and asymmetric diol libraries targeting aspartic proteases.
National University of Singapore
34
Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.
Kyoto Pharmaceutical University
4
New antiinfective and human 5-HT2 receptor binding natural and semisynthetic compounds from the Jamaican sponge Smenospongia aurea.
The University of Mississippi
4
Current development of 1,2,3-triazole derived potential antimalarial scaffolds: Structure- activity relationship (SAR) and bioactive compounds.
Central University of Punjab
17
Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin II.
Kyoto Pharmaceutical University
10
High antiplasmodial activity of novel plasmepsins I and II inhibitors.
University of Milan
25
Synthesis of malarial plasmepsin inhibitors and prediction of binding modes by molecular dynamics simulations.
Uppsala University
23
Design and synthesis of potent inhibitors of plasmepsin I and II: X-ray crystal structure of inhibitor in complex with plasmepsin II.
LinköPing University
83
Structural modification aimed for improving solubility of lead compounds in early phase drug discovery.
Indian Institute of Technology (B.H.U.)
10
4-Aryl Pyrrolidines as a Novel Class of Orally Efficacious Antimalarial Agents. Part 1: Evaluation of 4-Aryl- N-benzylpyrrolidine-3-carboxamides.
Saint Louis University
11
Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II.
University of California
4
Evaluation of a structure-based statine cyclic diamino amide encoded combinatorial library against plasmepsin II and cathepsin D.
Pharmacopeia
39
Plasmepsin Inhibitors in Antimalarial Drug Discovery: Medicinal Chemistry and Target Validation (2000 to Present).
University of Zambia
61
Exploiting Structural Dynamics To Design Open-Flap Inhibitors of Malarial Aspartic Proteases.
Latvian Institute of Organic Synthesis
28
Peptidomimetic plasmepsin inhibitors with potent anti-malarial activity and selectivity against cathepsin D.
Latvian Institute of Organic Synthesis
22
2-Aminoquinazolin-4(3H)-one based plasmepsin inhibitors with improved hydrophilicity and selectivity.
Latvian Institute of Organic Synthesis
3
Antiplasmodial activity of hydroxyethylamine analogs: Synthesis, biological activity and structure activity relationship of plasmepsin inhibitors.
University of Delhi
18
Novel isoindoline compounds for potent and selective inhibition of prolyl dipeptidase DPP8.
National Health Research Institutes
11
Cyclic HIV-1 protease inhibitors derived from mannitol: synthesis, inhibitory potencies, and computational predictions of binding affinities.
Uppsala University